Journal Article

A cohort autopsy study defines COVID-19 systemic pathogenesis

Zhang, Ding-Yu, Wang, Chao-Fu, Wu, Hai-Bo, Li, Tai-Sheng, Jiang, Dong-Po, Liu, Zhen-Hua, Wang, Yan, Luo, Tao, Ping, Yi-Fang, Li, Wei-Qin, Zhang, Shu-Yang, Jing, Rui, Bian, Xiu-Wu, He, Zhi-Cheng, Mao, Qing, Fei, Xiao-Chun, Fu, Wen-Juan, Yan, Ze-Xuan, Tang, Rui, Zhang, Heng, Ding, Yan-Qing, Chen, Cong, Li, Heng, Yin, Chang-Lin, Zhao, Lei, Ren, Yong, Wang, Juan, Huang, Xue-Quan, Xia, Xin-Yi, Chen, Rong, Zhang, Hua-Rong, Zhou, Xiang-Dong, Cai, Jun, Yao, Xiao-Hong, Liu, Xin-Dong, Shi, Yu, Zhang, Pei-Pei

2021

Overview

Severe COVID-19 disease caused by SARS-CoV-2 is frequently accompanied by dysfunction of the lungs and extrapulmonary organs. However, the organotropism of SARS-CoV-2 and the port of virus entry for systemic dissemination remain largely unknown. We profiled 26 COVID-19 autopsy cases from four cohorts in Wuhan, China, and determined the systemic distribution of SARS-CoV-2. SARS-CoV-2 was detected in the lungs and multiple extrapulmonary organs of critically ill COVID-19 patients up to 67 days after symptom onset. Based on organotropism and pathological features of the patients, COVID-19 was divided into viral intrapulmonary and systemic subtypes. In patients with systemic viral distribution, SARS-CoV-2 was detected in monocytes, macrophages, and vascular endothelia at blood–air barrier, blood–testis barrier, and filtration barrier. Critically ill patients with long disease duration showed decreased pulmonary cell proliferation, reduced viral RNA, and marked fibrosis in the lungs. Permanent SARS-CoV-2 presence and tissue injuries in the lungs and extrapulmonary organs suggest direct viral invasion as a mechanism of pathogenicity in critically ill patients. SARS-CoV-2 may hijack monocytes, macrophages, and vascular endothelia at physiological barriers as the ports of entry for systemic dissemination. Our study thus delineates systemic pathological features of SARS-CoV-2 infection, which sheds light on the development of novel COVID-19 treatment.

• Publisher: Springer Singapore,Nature Publishing Group
• Subject: 13/51 / 14/63 / 38/77 / 631/250 / 631/80/304 / Aged / Aged, 80 and over / Autopsies / Autopsy / Biomedical and Life Sciences / Blood / Cell Biology / Cell proliferation / China / Cohort Studies / Coronaviruses / COVID-19 / COVID-19 - pathology / COVID-19 - virology / Critical Illness / Female / Fibrosis / Hospitalization / Humans / Kidney - pathology / Kidney - virology / Leukocytes, Mononuclear - pathology / Leukocytes, Mononuclear - virology / Life Sciences / Lung - pathology / Lung - virology / Lung diseases / Lungs / Macrophages / Male / Middle Aged / Monocytes / Organotropism / Organs / Pathogenesis / Pathogenicity / Pathogens / Patients / RNA, Viral - metabolism / SARS-CoV-2 - genetics / SARS-CoV-2 - isolation & purification / Severe acute respiratory syndrome coronavirus 2 / Spleen - pathology / Spleen - virology / Trachea - pathology / Trachea - virology / Viral diseases